glp-1 ozempic There's still no generic Ozempic, but a lower-priced daily injected is coming Five Unexpected New Uses for

Discontinuation is associated with older age (65+ years), poor weight response, and moderate or severe GI side effects [70]

Clinical trials have shown that orforglipron results in just over 15% body weight loss in adults with obesity, placing it on par with that seen with Wegovy, but significantly lower than the 21% weight loss seen with Mounjaro

Both perspectives have merit

Conclusion The study found that GLP-1RA therapy is effective not only in managing blood glucose levels in individuals with type 2 diabetes but also in reducing body weight in obese individuals and changing unhealthy eating tendencies, such as the tendency to eat in response to external food cues (external eating)

I.TahraniA